CERBA RESEARCH USA, INC

CERBA RESEARCH USA, INC. specializes in centralized clinical laboratory services for complex biomedical research protocols, delivering high-compliance specimen processing, analytical testing, and data generation in support of multi-site clinical trials. Their technical expertise spans clinical chemistry, virology, and biomarker analysis, with demonstrated proficiency in managing large-scale, protocol-driven lab operations under stringent regulatory frameworks. The contractor excels in end-to-end central lab management, including sample receipt, aliquoting, storage, assay validation, and quality-controlled data reporting—critical for Phase I–IV trials involving global populations. Their work on SARS-CoV-2 support and cross-population chemistry panels underscores advanced capabilities in infectious disease diagnostics and ethnically stratified biomarker studies, positioning them as a trusted provider for precision medicine initiatives requiring rigorous analytical consistency. The company maintains a consistent relationship with the Department of Health and Human Services, primarily supporting public health research and emergency response initiatives through centralized lab services. Their engagements focus on delivering standardized, scalable laboratory workflows for federally funded clinical studies, often involving multi-center coordination and real-time data integration. This sustained partnership reflects deep familiarity with HHS’s operational requirements, including adherence to CLIA, CAP, and FDA guidelines for diagnostic testing in research settings. CERBA RESEARCH USA, INC. operates exclusively within the Medical Laboratories (NAICS 621511) category, specializing in clinical trial support services for pharmaceutical, biotech, and government-sponsored research. Their market positioning centers on providing regulated, high-throughput laboratory solutions tailored to the needs of complex, internationally coordinated trials, particularly in virology and metabolic biomarker analysis. As a 2L entity headquartered in New Hyde Park, New York, the company is structured to support federal research contracts with a focused, operational footprint. While no government certifications are disclosed, their consistent performance on HHS awards indicates established compliance with federal laboratory standards and quality management systems required for clinical research support.